Results 31 to 40 of about 17,628 (210)

Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer

International Journal of General Medicine, 2020
Yudi Mulyana Hidayat,1 Munizar,1 Ali Budi Harsono,1 Gatot Nyarumenteng Adhipurnawan Winarno,1 Hasanuddin,2 Siti Salima1 1Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; 2Department of Obstetrics ...
Hidayat YM, Munizar, Harsono AB, Winarno GNA, Hasanuddin, Salima S   +5 more
doaj  

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond

Frontiers in Oncology, 2019
Background: Oligometastatic disease has emerged as a possibly distinct metastatic phenotype in numerous cancer histologies. With the advancement in treatment modalities including stereotactic body radiation therapy (SBRT), certain patients may derive ...
Benjamin E. Onderdonk, Steven J. Chmura
doaj   +1 more source

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer [PDF]

Obstetrics & Gynecology Science, 2020
ObjectiveEpithelial ovarian cancer (EOC) requires an aggressive surgical approach. The important part of literature on ovarian cancer surgery emphasize residual tumor and survival analyses. Morbidity issue keeps in background.
Emre Günakan, Yusuf Aytaç Tohma, Mehmet Tunç, Hüseyin Akıllı, Hanifi Şahin, Ali Ayhan   +5 more
doaj   +1 more source

PD-1 Inhibitor (Sintilimab) Combined With Chemotherapy as Neoadjuvant Therapy in Advanced Ovarian Cancer: A Case Report. [PDF]

Clin Case Rep
ABSTRACT In a patient with advanced ovarian cancer showing limited response to paclitaxel–carboplatin, adding sintilimab was associated with R0 cytoreduction and sustained disease‐free status during olaparib–bevacizumab maintenance. This case provides a rationale for further investigation of PD‐1 blockade as neoadjuvant therapy in carefully selected ...
Zhenyan W, Yan W.
europepmc   +2 more sources

Erector Spinae Plane Catheters for Analgesia for Cytoreduction Surgery With Hyperthermic Intraperitoneal Chemotherapy: A Case Series

, 2022
Cytoreduction surgery with hyperthermic intraperitoneal chemotherapy is a complex and painful procedure that can cause postoperative hypotension and coagulopathy.
Loyd, Gary E, Fidkowski, Christina W, Giska, Mark A, Hussain, Adnan, McCurry, Cory, Younger, Joshua D   +5 more
core   +1 more source

The role of cytoreductive surgery and hyperthermic intraperitoneal chemytherapy in the treatment of rare histological subtypes of ovarian cancer [PDF]

Medicinski Podmladak
Malignant ovarian tumor is the eighth most common malignant tumor in the female population with an incidence rate of 6.6 and a mortality rate of 4.2 per 100,000 in the world.
Vasiljević Jovica, Pavlov Maja, Marković-Denić Ljiljana   +2 more
doaj   +1 more source

Thrombosis in myeloproliferative neoplasms during cytoreductive and antithrombotic drug treatment

Research and Practice in Thrombosis and Haemostasis, 2022
A state‐of‐the‐art lecture titled “Myeloproliferative Neoplasm‐associated Thrombosis” was presented at the ISTH congress in 2021. We summarize here the main points of the lecture with two purposes: to report the incidence rates of major thrombosis in ...
Tiziano Barbui, Alessandra Carobbio, Valerio De Stefano   +2 more
doaj   +1 more source

Perioperative Risks of Concurrent Pancreatic and Hepatic Resections for Neuroendocrine Tumors

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Pancreatic neuroendocrine tumors (pNETs) account for 1%–2% of pancreatic tumors, with an increasing incidence. The safety of concurrent pancreas‐liver resections remains uncertain. This study evaluated the national outcomes of concurrent pancreatectomy and liver‐directed surgery for pNETs. Methods ACS‐NSQIP (2019–2023)
Amir Ebadinejad, Ashrita Raghuram, Sophia Xiao, Ethan Angle, Hassan Aziz   +4 more
wiley   +1 more source

Morbidity and Mortality of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients Aged 70 Years and Older: A Two‐Center 10‐Year Experience

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is established for peritoneal surface malignancies, but its use in older patients is debated. We assessed CRS‐HIPEC morbidity and mortality in patients aged ≥ 70 years using a cohort of younger patients as a comparator.
Ali Ediz Kıvanç, Mehmet Oduncu, Pırıltı Özcan, Özgül Düzgün, Neşet Köksal   +4 more
wiley   +1 more source

Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer

, 2010
Background: Despite radical surgical and chemotherapeutic treatment of ovarian cancer, the majority of patients develop recurrent disease. Secondary cytoreductive surgery can result in favourable outcome in selected patients, but information regarding ...
Woelber, L., Jaenicke, F., Schwarz, J., Jung, S., Mahner, S., Mueller, V., Eulenburg, C., S. Jung, V. Mueller, C. Eulenburg, S. Mahner, F. Jaenicke, L. Woelber, J. Schwarz   +13 more
core   +1 more source